GLPwatch
Trials (2081)
Page 25 of 35.
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- The Effects of Semaglutide on Body Composition and Performance in Military Personnel
- Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
- Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
- Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
- SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Semaglutide and Vascular Regeneration
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
- Liraglutide and Heart Failure in Type 2 Diabetes
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
- Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
- To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
- Preoperative Condition in Giant Obese Patients
- Subcutaneous Semaglutide in Systemic Scleroderma
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
- The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
- A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
- Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
- Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
- Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
- Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
- Semaglutide to Reduce Atrial Fibrillation Burden
- A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
- Tirzepatide in MetALD
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
- Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
- Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes